Patent US2650606A successfully refreshed from Google Patents.
Patent US4049791A successfully refreshed from Google Patents.
US4049791A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Prolonged acting appetite suppressant and anti-obesity compositions containing amphetamine adipate, dextroamphetamine adipate, amphetamine sulfate and dextroamphetamine sulfate as the active agents
Assignee: LEMMON Co A CORP OF
•
Filing: 1976-01-26
•
Granted: 1977-09-20
•
Expires: 1996-01-26
Abstract
Abstract A prolonged acting appetite suppressant and anti-obesity composition in oral administration form which comprises an effective amount of a synergistic combination of amphetamine adipate, dextroamphetamine adipate, amphetamine sulfate and dextroamphetamine sulfate in equal or substantially equal amounts as the active agents in combination with a pharmaceutically acceptable carrier and is useful in suppressing one's appetite and in treating obesity.
Inventors
- 👤 Louis Cohen
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-04 15:43
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/185; A61K31/205; A61K9/00; A61K9/48; A61K9/50; A61K9/5073; A61K9/5078
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
37 words
The composition in which each dosage unit consists of, per 5 mg of active agent, a synergistic combination of: ______________________________________
d,1-amphetamine adipate 1.25 mg
dextroamphetamine adipate
1.25 mg
amphetamine sulfate 1.25 mg
dextroamphetamine sulfate
1.25 mg.
______________________________________
Claim 2
Dependent Claim
37 words
The composition in which each dosage unit consists of, per 5 mg of active agent, a synergistic combination of: ______________________________________
d,1-amphetamine adipate 1.25 mg
dextroamphetamine adipate
1.25 mg
amphetamine sulfate 1.25 mg
dextroamphetamine sulfate
1.25 mg.
______________________________________
Claim 3
Dependent Claim
40 words
The composition of claim 1 in which each dosage unit consists of 10 mg of active agent as a synergistic combination of: ______________________________________
d,1-amphetamine adipate
2.5 mg
dextroamphetamine adipate
2.5 mg
amphetamine sulfate 2.5 mg
dextroamphetamine sulfate
2.5 mg.
______________________________________
Claim 4
Dependent Claim
40 words
The composition of claim 1 in which each dosage unit consists of 15 mg of active agent as a synergistic combination of: ______________________________________
d,1-amphetamine adipate
3.75 mg
dextroamphetamine adipate
3.75 mg
amphetamine sulfate 3.75 mg
dextroamphetamine sulfate
3.75 mg.
______________________________________
Claim 5
Dependent Claim
40 words
The composition of claim 1 in which each dosage unit consists of 20 mg of active agent as a synergistic combination of: ______________________________________
d,1-amphetamine adipate
5 mg
dextroamphetamine adipate
5 mg
amphetamine sulfate 5 mg
dextroamphetamine sulfate
5 mg.
______________________________________
Claim 6
Dependent Claim
39 words
The composition according to claim 1 which comprises a tablet containing 5 mg of active agent, which tablet consists of: ______________________________________
dextroamphetamine adipate
1.25 mg
amphetamine adipate 1.25 mg
dextroamphetamine sulfate, USP
1.25 mg
amphetamine sulfate 1.25 mg.
______________________________________
Claim 7
Dependent Claim
13 words
A composition according to claim 1 which is in unit dosage tablet form.
Claim 8
Dependent Claim
43 words
A composition according to claim 1 wherein the active agents in the capsule are in the form of coated seeds which have coatings of different thicknesses or solubilities whereby the active agents are released incrementally over a period of 6 to 8 hours.
Claim 9
Dependent Claim
25 words
A composition according to claim 1 in capsule form in which each active agent is present in each capsule in the amount of 1.25 mg.
Claim 10
Dependent Claim
25 words
A composition according to claim 2 in tablet form in which each active agent is present in each tablet in the amount of 2.5 mg.
Claim 11
Dependent Claim
28 words
A composition according to claim 3 in sustained release form in capsules in which each active agent is present in each capsule in the amount of 3.75 mg.
Claim 12
Dependent Claim
28 words
A composition according to claim 4 in sustained release form in capsules in which each active agent is present in each capsule in the amount of 5 mg.
References Cited (Backward Citations)
US3304230A
Cited
US3608063A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1980-09-19 | 1981-03-21 | 1981-09-20 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1984-09-19 | 1985-03-21 | 1985-09-20 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1988-09-19 | 1989-03-21 | 1989-09-20 | $7700.00 | Window Closed / Lapsed |